Novo Nordisk reported 26.5B in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
Bausch Health Companies USD 148M 206M Jun/2025
Bristol-Myers Squibb USD 1.31B 1.15B Jun/2025
Eli Lilly USD 5.66B 2.9B Jun/2025
GlaxoSmithKline GBP 1.44B 181M Jun/2025
Merck USD 4.43B 652M Jun/2025
Novartis USD 4.02B 418M Jun/2025
Novo Nordisk 26.5B 2.53B Jun/2025
Novo Nordisk DKK 29.03B 1.73B Mar/2025
Pacira USD -4847000 9.66M Jun/2025
Sanofi EUR 3.94B 2.07B Jun/2025
Supernus Pharmaceuticals USD 22.5M 34.33M Jun/2025